Keyphrases
Type 1 Diabetes Mellitus (T1DM)
100%
Newly Diagnosed
100%
Hematopoietic Stem Cell Transplantation
100%
Nonmyeloablative
100%
Immunosuppression
37%
Insulin
37%
Serum Levels
25%
High Dose
25%
Cyclophosphamide
25%
Hemoglobin A1c (HbA1c)
25%
Diabetic Ketoacidosis
25%
Glutamic Acid Decarboxylase 65 (GAD65)
25%
School of Medicine
12%
Cryopreserved
12%
Hyperglycemia
12%
Cell-mediated
12%
Transplantation
12%
Peripheral Blood
12%
Hematopoietic Stem Cells
12%
β-cell Function
12%
Pancreatic β-cells
12%
Antibody Level
12%
Autoimmune
12%
Metabolic Effects
12%
Daily Dose
12%
Number of Patients
12%
Temporal Change
12%
Endocrine Disorders
12%
Bone Marrow Transplantation
12%
Brazil
12%
Leukapheresis
12%
Granulocyte Colony-stimulating Factor (G-CSF)
12%
Antibody Titer
12%
Insulin Production
12%
Insulin Dose
12%
Insulin Independence
12%
Hypothyroidism
12%
Safety Impact
12%
Glutamate Decarboxylase
12%
Meal Tolerance Test
12%
Hypogonadism
12%
Exogenous Insulin
12%
Antithymocyte Globulin
12%
Trial Registration
12%
Acute Severe
12%
Response Curve
12%
Phase 1/2 Study
12%
Late Response
12%
Insulin Requirement
12%
Severe Adverse Effects
12%
C-peptide Response
12%
C-peptide Levels
12%
Bilateral Pneumonia
12%
Medicine and Dentistry
Nonmyeloablative Stem Cell Transplantation
100%
Insulin Dependent Diabetes Mellitus
100%
Immunosuppressive Treatment
37%
Cyclophosphamide
25%
Drug Megadose
25%
Glutamate Decarboxylase Antibody
25%
C-Peptide
25%
Hemoglobin A1c
25%
Diabetic Ketoacidosis
25%
Beta Cell
25%
Adverse Event
12%
Bone Marrow Transplantation
12%
Granulocyte Colony Stimulating Factor
12%
Thymocyte Antibody
12%
Cell Function
12%
Hypothyroidism
12%
Hematopoietic Cell
12%
Endocrine Disease
12%
Hyperglycemia
12%
Clinical Finding
12%
Leukapheresis
12%
Clinical Study
12%
Hypogonadism
12%
Factor X
12%
Patient with Type 1 Diabetes
12%
Conditioning
12%
Medicine
12%
Glutamate Decarboxylase
12%
Neuroscience
Diabetes Mellitus Type 1
100%
Hematopoietic Cell
100%
Immunosuppression
33%
Cyclophosphamide
22%
Beta Cell
22%
Hemoglobin A1c
22%
Glutamate Decarboxylase Antibody
22%
C Peptide
22%
Diabetes Mellitus
22%
Glutamate Decarboxylase
11%
Hyperglycemia
11%
Anti-Thymocyte Globulin
11%
Granulocyte Colony-Stimulating Factor
11%
Adverse Effect
11%
Cell Function
11%
Endocrine Disease
11%
Factor X
11%
Hypothyroidism
11%
Hypogonadism
11%
Immunology and Microbiology
Diabetes Mellitus Type 1
100%
Nonmyeloablative Stem Cell Transplantation
100%
Immunosuppression
37%
Blood Level
25%
Drug Megadose
25%
Glutamate Decarboxylase Antibody
25%
Cyclophosphamide
25%
Bone Marrow Transplantation
12%
Cell Function
12%
Conditioning
12%
Granulocyte Colony-Stimulating Factor
12%
Anti-Thymocyte Globulin
12%
Hematopoietic Cell
12%
Leukapheresis
12%
Antibody Titer
12%
Immunology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Insulin Dependent Diabetes Mellitus
100%
Cyclophosphamide
33%
Hemoglobin A1c
33%
C Peptide
33%
Glutamate Decarboxylase Antibody
33%
Diabetic Ketoacidosis
33%
Clinical Study
16%
Adverse Event
16%
Hypogonadism
16%
Thymocyte Antibody
16%
Granulocyte Colony Stimulating Factor
16%
Blood Clotting Factor 10
16%
Hyperglycemia
16%
Endocrine Disease
16%
Glutamate Decarboxylase
16%
Hypothyroidism
16%
Biochemistry, Genetics and Molecular Biology